These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 15551293)

  • 41. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
    Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
    Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.
    Bodmer M; Sulz M; Stadlmann S; Droll A; Terracciano L; Krähenbühl S
    Digestion; 2006; 74(1):28-32. PubMed ID: 16988508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 44. [Preliminary study on the safety and pharmacodynamic action of low dose L-asparaginase].
    Wu ZL; Chen FX; Ye TZ; Lai YH; Cui YQ; Zou YW; Lu CY; Lan SL; Zhong GY; Guan JM; Wei FG; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):14-6. PubMed ID: 16732932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
    Ylikangas P; Mononen I
    Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
    Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
    Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
    Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-asparaginase related hyperglycemia.
    Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
    Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
    Christ TN; Stock W; Knoebel RW
    J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
    Sutor AH; Mall V; Thomas KB
    Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
    Boos J
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia.
    Semeraro N; Montemurro P; Giordano P; Schettini F; Santoro N; De Mattia D; Giordano D; Conese M; Colucci M
    Thromb Haemost; 1990 Aug; 64(1):38-40. PubMed ID: 2274927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia.
    Steiner M; Attarbaschi A; Kastner U; Dworzak M; Haas OA; Gadner H; Mann G
    Pediatr Blood Cancer; 2007 Oct; 49(5):640-2. PubMed ID: 16941647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
    Castaman G; Rodeghiero F; Dini E
    Haematologica; 1990; 75(6):567-9. PubMed ID: 2098299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
    Tsutsui M; Koike M; Komatsu N
    Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.